The chemokine, through its CCL2-CCR2 axis, polarizes the monocytes to TAMs, resulting in tumor cell survival, and the inhibition of CCL2-CCR2 signaling blocks the recruitment of inflammatory cells to the tumor site, reducing tumor progression and metastasis [128]. The gene discussed is CCR2; the disease is neoplasm.